Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. - Wikidata - awgldk - TriplyDB

Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.

Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.

http://www.wikidata.org/entity/Q37233208

about

Oxidation of marine omega-3 supplements and human health GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Skeletal Muscle Mitochondrial Bioenergetics and Morphology in High Fat Diet Induced Obesity and Insulin Resistance: Focus on Dietary Fat Source Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders Biological Roles of Resolvins and Related Substances in the Resolution of Pain (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases Omega-3s and cardiovascular health.Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans Roles of resolvins in the resolution of acute inflammation 12- and 15-lipoxygenases in adipose tissue inflammation The effects of diet-induced obesity on B cell function Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acids Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation Nutritional approaches for managing obesity-associated metabolic diseases.Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease.Specialized pro-resolving lipid mediators in the inflammatory response: An update Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?Proresolving lipid mediators and diabetic wound healing Monitoring the efficacy of omega-3 supplementation on liver steatosis and carotid intima-media thickness: a pilot study.Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice.Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis.Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1.Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.Oxidative stress and metabolic pathologies: from an adipocentric point of view.Altered cholesterol and fatty acid metabolism in Huntington disease Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury.Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.Resolution, the grail for healthy ocular inflammation.AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids.Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis Molecular biology for formyl peptide receptors in human diseases.SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice.Resolvins: natural agonists for resolution of pulmonary inflammation.

P2860

Q21284850-DFBB42A1-0627-4EB4-8C41-4BD83993DA93 Q24630455-B33F315A-2BAA-40CF-82B8-C20F5C195372 Q26772781-F343D23E-15B9-4BD9-AA31-4B1C7D9C6060 Q26779189-662DE12C-8112-44B9-B348-36C487DE44D5 Q26784433-685CDF37-2177-40B4-AE40-9EAFADC49034 Q27013554-7511EFBA-609D-42B6-8906-8BF9F6351465 Q27021694-EACF074F-F1DD-48FC-8C50-08875C1FDDB0 Q27686781-C20B9AD3-98BA-448C-96DB-395EF0FC4EF5 Q28075256-EA470401-72E7-492C-887C-8DCA77104747 Q28244502-384E2B73-E4F8-4145-8C2B-A6BF75CF143D Q28274315-B144B89D-80DF-448C-AD22-6F4D05A5E5E9 Q28383934-9EC19266-BCF4-4C93-8DB5-45879B286F09 Q28386488-7D442734-4E94-493F-A14E-3E13B445B566 Q28387661-B6EADE18-6CB1-40DA-8E8E-5A0B737F0BDF Q28533399-5644423A-2EFB-4082-9E18-676C8D5B8744 Q28716294-6FB4C289-A046-4B5E-9B07-5F995B969948 Q30234850-E7D48B77-DD9C-4E42-885B-3C9385905CF5 Q33556241-58BD8C84-9840-4333-9D78-3FC9EAFB27C4 Q33564624-57A31F05-8AA2-4D73-BC98-CA02E72C343B Q33631285-266118C9-99B7-401D-BA38-3FB7327352D0 Q33657562-00BAA0A8-2E11-4A82-9085-AB25EE9BB075 Q33683210-7DF7466D-DCB2-4DDF-AA82-B0365988F248 Q33683848-5DD3309B-BD7C-4862-9CA4-74E7CC5F67E7 Q33819770-D9064473-1441-44E4-8572-3CCE45484B88 Q33832505-72C965AC-4E22-480B-B675-458DF143A983 Q33881724-77C2A998-2F27-4A8C-814D-17C74C2C8DEA Q33993206-048A5CF2-CF2C-412C-B501-0766265900FA Q34027672-D84DF03F-2F6A-452B-ABF1-8A996B6A7026 Q34038044-FCD7C8D2-4564-48CE-BA80-1DD81350B532 Q34080706-E86ED61C-6D83-4FBF-A67C-3D5BCD7A0C66 Q34097903-B3004B84-436C-45AA-8829-6A53D234EEE4 Q34103130-5E764890-A4E6-4A29-9332-27B22F6406FD Q34113615-AFF12CAC-A655-47C5-8D4F-51D62610AF91 Q34126362-CDC0ED33-F1C3-44B7-8167-F3F2EF5DA083 Q34237595-477C4148-D6EF-4B4B-8093-2C0687E22393 Q34243636-B2F8F9E8-B86A-4677-BF53-2D3C73291003 Q34327503-30410144-00E9-47D7-94D1-3F47F760DD8E Q34333647-C6FA3E8F-0FC3-40F6-B858-34E1A07D4C36 Q34355211-44D175CB-E759-4CB1-9AFC-FCC0D93A80CD Q34448487-5701C950-0012-4376-98D7-767BA6FC7C38

P2860

Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.

http://www.wikidata.org/entity/Q37233208

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Obesity-induced insulin resist ...... for resolvins and protectins.

@en

Obesity-induced insulin resist ...... for resolvins and protectins.

@nl

type

label

Obesity-induced insulin resist ...... for resolvins and protectins.

@en

Obesity-induced insulin resist ...... for resolvins and protectins.

@nl

prefLabel

Obesity-induced insulin resist ...... for resolvins and protectins.

@en

Obesity-induced insulin resist ...... for resolvins and protectins.

@nl

P1433

Q37233208-31D665F4-AAE2-48B2-B6DE-1CD9C938F27C

P1476

Q37233208-F902BED5-D5DD-44A6-947F-0D83D89B36AC

P2093

Q37233208-0A727EB3-ED61-4359-BE4A-3860C7ECD502

Q37233208-2E7AE0A1-46BA-4B31-ADFB-D0D4EB60E4A0

Q37233208-39753DA6-7EE1-4F59-B64B-535149A71D16

Q37233208-4C03BAF6-E418-4476-9979-FF351839D409

Q37233208-6CD6E6DF-B7C1-4715-8D61-D14DEE06B34E

Q37233208-7B08E506-FFFA-4009-A479-90C63F1BCEC1

Q37233208-90007699-1EB5-4AF9-B39C-2FD67E1B8D97

Q37233208-D56C13C3-12FD-4DA4-A80A-0DB12B1D24A6

Q37233208-F33D5D36-6886-4274-A276-748144498DFF

Q37233208-F93D3A96-368C-4945-BF6F-085925985961

P2860

Q37233208-04AD95CE-1F7A-4CAD-A201-D2A654AC3A49

Q37233208-127D8BD5-20B5-4FD4-89E8-51EF40AF7A36

Q37233208-14625205-6F9B-4701-A2B1-5872CD647907

Q37233208-15414655-CB41-4622-9CD3-173024FE91F2

Q37233208-23EBDB8B-92F8-4993-B61F-6E41F5E34996

Q37233208-33EA1BAB-D51A-42CF-B14E-6EC676F0F107

Q37233208-3F47E9F7-1956-44B5-9A21-EB97DF65096D

Q37233208-4972D689-AF19-4D00-97EE-F7041911E586

Q37233208-49BC2623-D4E7-4E77-B84B-F6BA76E25F64

Q37233208-4F71E3BB-FBFB-495D-BE24-26A04EA5CAF9

P304

Q37233208-2CD069BD-5751-4850-934C-6E8B786C6DAA

P31

Q37233208-C5915135-96D9-4DD8-8B71-A52505AD9AD6

P356

Q37233208-8E22E87F-69C3-4BF8-B2EA-A8A5D0345CAE

P407

Q37233208-1B561156-5C8B-4177-8556-D6F9CFA31BF0

P433

Q37233208-0CBF0DFC-0256-414B-9703-D118628097F3

P478

Q37233208-513E8EAA-96E6-4F1F-A179-D88FE1C5C0E3

P577

Q37233208-222D23D0-EC46-423C-8BA4-DF186B1BD66C

P698

Q37233208-82ECAD60-58CC-4202-9864-D3A2289DFA59

P921

Q37233208-310B5DFB-6B39-4A3D-9DF5-BFF4AE80101E

Q37233208-5385DD5B-32C2-4338-BFFD-6FC20D6D1E2E

Q37233208-5A6F39DD-BC82-4136-92AA-2E518807F227

P932

Q37233208-52985117-3082-48F1-BC6F-FF79530A7173

P356

P1433

P1476

Obesity-induced insulin resist ...... for resolvins and protectins.

@en

P2093

Ana González-Périz

http://www.w3.org/2001/XMLSchema#string

Baiyan Dong

http://www.w3.org/2001/XMLSchema#string

Esther Titos

http://www.w3.org/2001/XMLSchema#string

Eva Morán-Salvador

http://www.w3.org/2001/XMLSchema#string

Joan Clària

http://www.w3.org/2001/XMLSchema#string

Karsten Gronert

http://www.w3.org/2001/XMLSchema#string

Marcos Martínez-Clemente

http://www.w3.org/2001/XMLSchema#string

Marta López-Parra

http://www.w3.org/2001/XMLSchema#string

Natàlia Ferré

http://www.w3.org/2001/XMLSchema#string

Raquel Horrillo

http://www.w3.org/2001/XMLSchema#string

P2860

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis

A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

Nonalcoholic fatty liver disease

P304

1946-1957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.08-125674

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19211925

http://www.w3.org/2001/XMLSchema#string

P921

P932

2698663

http://www.w3.org/2001/XMLSchema#string